Although studies provided conflicting interpretations of the prognostic value of BRCA1 mutation in BC patients (Lee et al., 2010; Copson et al., 2018), patients with BRCA1 mutation may be sensitive to platinum salts and PARP inhibitors, which could significantly prolong survival time. The gene discussed is BRCA1; the disease is breast cancer.